Trial Profile
Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2017
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine/atropine
- Indications Cognition disorders
- Focus Therapeutic Use
- 01 Sep 2017 Results published in the Anaesthesia and Intensive Care.
- 29 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 20 Apr 2015 New trial record